Literature DB >> 26707067

Adenosine deaminase is a useful biomarker to diagnose pleural tuberculosis in low to medium prevalence settings.

Jean-Marie Michot1, Yoann Madec2, Sophie Bulifon3, Cécile Thorette-Tcherniak3, Nicolas Fortineau4, Nicolas Noël5, Olivier Lambotte5, Younes El Jahiri6, Hervé Delacour6, Jean-François Delfraissy5, François-Xavier Blanc7.   

Abstract

Adenosine deaminase (ADA) activity measurement in pleural fluid is a relevant test to diagnose pleural tuberculosis (pTB) in high tuberculosis prevalence settings. We investigated the diagnostic utility of pleural ADA using a retrospective analysis of patients admitted with newly diagnosed pleural effusion without identified etiology between 2001 and 2008 in Paris suburb, a low to medium tuberculosis prevalence area. 104 adults (mean age 55 years; 34 with pTB, 70 with other diagnoses) were analyzed. Median follow-up was 15.6 months. Mean [interquartile range] pleural ADA was 119 U/L [IQR: 83-143] in pTB and 24 U/L [IQR: 15-31] in non-tuberculous effusions (P<0.001). With an optimal pleural ADA cut-off value of 41.5 U/L for pTB diagnosis, sensitivity and specificity were 97.1% and 92.9%, while positive and negative predictive values were 86.8% and 98.5%, respectively. We conclude that pleural ADA activity could be integrated in the diagnostic procedures of pTB in low to medium tuberculosis prevalence settings.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biological marker; Mycobacterium tuberculosis; Pleural effusion

Mesh:

Substances:

Year:  2015        PMID: 26707067     DOI: 10.1016/j.diagmicrobio.2015.11.007

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  5 in total

1.  Bayesian latent class analysis produced diagnostic accuracy estimates that were more interpretable than composite reference standards for extrapulmonary tuberculosis tests.

Authors:  Emily L MacLean; Mikashmi Kohli; Lisa Köppel; Ian Schiller; Surendra K Sharma; Madhukar Pai; Claudia M Denkinger; Nandini Dendukuri
Journal:  Diagn Progn Res       Date:  2022-06-16

2.  Development and validation of a prediction model for tuberculous pleural effusion: a large cohort study and external validation.

Authors:  Yanqing Liu; Zhigang Liang; Songbo Yuan; Shanshan Wang; Fei Guo; Weidong Peng; Jing Yang; Aihua Wu
Journal:  Respir Res       Date:  2022-05-27

3.  Diagnostic accuracy of adenosine deaminase for pleural tuberculosis in a low prevalence setting: A machine learning approach within a 7-year prospective multi-center study.

Authors:  Alberto Garcia-Zamalloa; Diego Vicente; Rafael Arnay; Arantzazu Arrospide; Jorge Taboada; Iván Castilla-Rodríguez; Urko Aguirre; Nekane Múgica; Ladislao Aldama; Borja Aguinagalde; Montserrat Jimenez; Edurne Bikuña; Miren Begoña Basauri; Marta Alonso; Emilio Perez-Trallero
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

4.  Plasma Adenosine Deaminase (ADA)-1 and -2 Demonstrate Robust Ontogeny Across the First Four Months of Human Life.

Authors:  Oludare A Odumade; Alec L Plotkin; Jensen Pak; Olubukola T Idoko; Matthew A Pettengill; Tobias R Kollmann; Al Ozonoff; Beate Kampmann; Ofer Levy; Kinga K Smolen
Journal:  Front Immunol       Date:  2021-05-27       Impact factor: 7.561

5.  Adenosine deaminase negative pleural tuberculosis: a case report.

Authors:  Zachary H Boggs; Scott Heysell; Joshua Eby; Christopher Arnold
Journal:  BMC Infect Dis       Date:  2021-06-15       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.